Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ferrer to distribute DiaGenic test in Europe and Latin America

This article was originally published in Clinica

Executive Summary

Personalised medicine specialist Ferrer inCode (Barcelona, Spain) is to become the exclusive distributor of DiaGenic’s ADtect test for early diagnosis of Alzheimer’s disease in 32 countries across Europe and Latin America. Ferrer, which is part of pharmaceutical device group Grupo Ferrer International, will market and sell ADtect in key European markets such as Germany, the Netherlands, France, Spain and Italy. ADtect differs to other Alzheimer’s tests, as it uses peripheral blood as the sample material to provide early, noninvasive diagnosis of the disease. According to Oslo, Norway-based DiaGenic, Alzheimer’s afflicts around 30 million people worldwide and treatment-related costs were estimated at $315bn in 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045301

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel